However, there is a subgroup, of 1–6% of adult and childhood T-ALL that is characterized by the presence of an MYC translocation that is associated with high rates of CDKN2A/B deletions (75%). This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.